Strategic acquisitions STERIMED has recently expanded through UK-based Riverside Medical Packaging and Westfield Medical acquisitions, signaling a growth trajectory and integration potential for cross-border packaging capabilities, enabling upsell of enhanced sterilization packaging solutions and services.

Global footprint With 1,500 employees across 17 countries on three continents, there is a broad regional demand base and potential to upsell standardized sterilization packaging solutions to hospitals, medical device manufacturers, and pharmaceutical clients worldwide seeking reliable supply continuity.

Product innovation Recent substrate launches like Polybond CGP and CGP 85 indicate a focus on advanced, intelligent packaging materials, presenting opportunities to position premium, traceable packaging solutions to customers aiming for enhanced sterility assurance and compliance.

Leadership lineage Founding involvement and continued director-level stake by Sterimed’s founder suggests a stable management vision and potential for long-term partnerships; leverage this to establish trust-based, multi-year procurement agreements with risk mitigation.

Market focus As a global leader in infection prevention packaging serving medical device manufacturers and hospitals, there is a clear cross-sell path to expand into pharmaceutical packaging needs and associated sterilization services, tapping into adjacent demand within your current customer ecosystem.